世界の微生物識別市場動向と予測（～2019）...市場調査レポートについてご紹介

Table of Contents

1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Market Scope
1.6 Research Methodology
1.6.1 Market Size Estimation
1.6.2 Market Breakdown and Data Triangulation
1.6.3 Market Share Estimation
1.6.4 Key Data From Secondary Sources
1.6.5 Key Data Points From Primary Sources
1.6.6 Assumptions

2 Executive Summary (Page No. – 31)

3 Market Overview (Page No. – 35)
3.1 Introduction
3.2 Market Segmentation
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Rising Incidences of Infectious Diseases Coupled With Pandemic Events Are Likely to Drive the Growth of the Clinical Microbiology Market
3.3.1.2 Technological Advancements to Propel the Market
3.3.1.3 Increasing Food Safety Concerns to Goad the Microbial Identification Market
3.3.1.4 High Healthcare Spending and Focus on Development of Healthcare Infrastructure to Propel the Market in Emerging Economies
3.3.1.5 Government Initiatives and Funding to Propel Market Growth
3.3.2 Restraints
3.3.2.1 Complex Regulatory Framework That Delays Approval of New Microbial Diagnostic Tests Likely to Hamper Market Growth
3.3.2.2 High Costs of Automated Microbial Identification Systems to Restrain Market Growth
3.3.3 Opportunities
3.3.3.1 Detection of Antimicrobial-Resistant Species Provides Growth Opportunities for the Market
3.3.3.2 Emerging Economies Present Significant Growth Opportunities
3.3.3.3 Bioterrorism Surveillance Provides Significant Growth Prospects
3.3.4 Challenges
3.3.4.1 Market Cannibalization of Existing Technologies By New and Upcoming Technologies
3.3.4.2 Survival of Small Players and New Entrants
3.3.5 Trends
3.3.5.1 Shift From the Conventional Phenotypic to Genotypic Identification Techniques
3.3.5.2 Growing Focus on Maldi Tof-Based Applications in Identification
3.3.5.3 Rising Impetus for Food Pathogen Identification
3.4 Markets Share Analysis

4 Global Microbial Identification Market, By Products (Page No. – 51)
4.1 Introduction
4.2 Consumables
4.2.1 Plates and Media
4.2.2 Reagents and Kits
4.2.3 Other Consumables
4.3 Instruments and Software
4.3.1 Automated Microbial Detection Systems
4.3.2 PCR
4.3.3 Mass Spectrometers
4.3.4 High-Power Microscopes
4.3.5 Microarrays
4.3.6 Polystainers
4.3.7 Flow Cytometers
4.3.8 Other Instruments
4.4 Services
4.4.1 Identification Services
4.4.2 Culture Collection Services

5 Global Microbial Identification Market, By Method (Page No. – 82)
5.1 Introduction
5.2 Phenotypic Methods
5.3 Genotypic Methods

6 Global Microbial Identification Market, By Applications (Page No. – 94)
6.1 Introduction
6.2 Diagnostic Applications
6.2.1 Human Disease Diagnosis
6.2.2 Animal Disease Diagnosis
6.3 Food & Beverage Testing
6.4 Pharmaceutical Applications
6.5 Environmental Applications

7 Global Microbial Identification Market, By End User (Page No. – 109)
7.1 Introduction
7.2 End Users for Microbial Detection and Enumeration
7.2.1 Government/Private Institutes, Hospitals, and Blood Banks
7.2.2 Food and Beverage Manufacturers
7.2.3 Pharmaceutical Companies and Cros
7.2.4 Environmental Study Agencies, Ngos, and Research Laboratories
7.3 End Users for Microbial Characterization
7.3.1 Government/-Private Institutes, Hospitals, and Diagnostic Laboratories
7.3.2 Pharmaceutical Companies and Cros
7.3.3 Independent Research Laboratories
7.4 Culture Collection Repositories

8 Global Microbial Identification Market, By Geography (Page No. – 133)
8.1 Introduction
8.2 North America
8.3 Europe
8.4 Asia-Pacific
8.5 Rest of the World

9 Competitive Landscape (Page No. – 170)
9.1 Introduction
9.2 Partnerships, Agreements, and Collaborations
9.3 New Product Launches
9.4 Acquisitions
9.5 Expansions
9.6 Approval

10 Company Profiles (Page No. – 193)
10.1 Becton, Dickinson and Company
10.1.1 Business Overview
10.1.2 Company Snapshot
10.1.3 Product Portfolio
10.1.4 Key Strategy
10.1.5 Recent Developments
10.1.6 SWOT
10.1.7 MNM View
10.2 Biomérieux Sa
10.2.1 Business Overview
10.2.2 Company Snapshot
10.2.3 Product Portfolio
10.2.4 Key Strategy
10.2.5 Recent Developments
10.2.6 SWOT
10.2.7 MNM View
10.3 Bruker Corporation
10.3.1 Business Overview
10.3.2 Company Snapshot
10.3.3 Product Portfolio
10.3.4 Key Strategy
10.3.5 Recent Developments
10.3.6 SWOT
10.3.7 MNM View
10.4 Siemens Healthcare (Subsidary of Siemens AG)
10.4.1 Business Overview
10.4.2 Company Snapshot
10.4.3 Product Portfolio
10.4.4 Key Strategy
10.4.5 Recent Developments
10.4.6 SWOT
10.4.7 MNM View
10.5 Thermo Fisher Scintific, Inc.
10.5.1 Business Overview
10.5.2 Company Snapshot
10.5.3 Product Portfolio
10.5.4 Key Strategy
10.5.5 Recent Developments
10.5.6 SWOT
10.5.7 MNM View
10.6 Biolog Inc.
10.6.1 Business Overview
10.6.2 Financials
10.6.3 Product Portfolio
10.6.4 Key Strategy
10.6.5 Recent Developments
10.7 Charles River Laboratories Inc.
10.7.1 Business Overview
10.7.2 Company Snapshot
10.7.3 Products & Services
10.7.4 Key Strategy
10.7.5 Recent Developments
10.8 MIDI Inc.
10.8.1 Business Overview
10.8.2 Financials
10.8.3 Product Portfolio
10.8.4 Key Strategy
10.8.5 Recent Developments
10.9 Qiagen N.V.
10.9.1 Business Overview
10.9.2 Company Snapshot
10.9.3 Product Portfolio
10.9.4 Key Strategy
10.9.5 Recent Developments
10.10 Shimadzu Corporation
10.10.1 Business Overview
10.10.2 Company Snapshot
10.10.3 Product Portfolio
10.10.4 Strategy
10.10.5 Recent Developments
10.11 Sigma-Aldrich Corporation
10.11.1 Business Overview
10.11.2 Company Snapshot
10.11.3 Product Portfolio
10.11.4 Key Strategy
10.11.5 Recent Development